We are a science-led global healthcare company that researches and develops a broad range of innovative products in three primary areas of pharmaceuticals, vaccines and consumer healthcare.

As one of the few healthcare companies researching both medicines and vaccines for the World Health Organization’s three priority diseases – HIV/AIDS, tuberculosis and malaria, we are very proud to have developed some of the leading global medicines in these fields.

Brentford, GB
101,192 (est)+3%
GlaxoSmithKline is headquartered in Brentford, GB

Key People at GlaxoSmithKline

Andrew Philip Witty

Andrew Philip Witty

Emma Walmsley

Emma Walmsley

CEO of GSK Consumer Healthcare
Simon Dingemans

Simon Dingemans

David Redfern

David Redfern

Dan Troy

Dan Troy

General Counsel
Philip Thomson

Philip Thomson

SVP Global Communications & Government Affairs

GlaxoSmithKline Locations

Brentford, GB
Cincinnati, US
Dorset, GB
Washington, US
Mexico City, MX
Baku, AZ
Parsippany-Troy Hills, US
Tirana, AL
Boudouaou Est, DZ
Yerevan, AM
Boronia, AU
Wien, AT
Baltimore, US
Bangladesh, IN
Minsk, BY
Wavre, BE
Bogotá, CO
Izmir, TR

GlaxoSmithKline Metrics

GlaxoSmithKline Summary

Market capitalization

$94.2 B

Closing share price

GlaxoSmithKline's current market capitalization is $94.2 B.

GlaxoSmithKline Financials

We estimate that GlaxoSmithKline's revenue is £23.9 B in FY, 2015 which is 3.99% increase from the previous period.
FY, 2013FY, 2014FY, 2015


£26.5 B£23 B£23.9 B

Revenue growth, %


Cost of sales

£8.59 B£7.32 B£8.85 B

Gross profit

£17.9 B£15.7 B£15.1 B

Gross profit Margin, %


Operating expense total

£10.9 B£12.1 B£4.75 B

    GlaxoSmithKline Market Value History

    GlaxoSmithKline Online Presence

    GlaxoSmithKline News

    GlaxoSmithKline Company Life

    You may also be interested in